Genetic Technologies Stock Forecast for 2023 - 2025 - 2030

Updated on 04/27/2024

Stock Rating
0
Price Target
$0.06
Consensus
Downside
-50.00%
Analysts
0
Stock Rating
0
Downside
-50.00%
Analysts
0
Price Target
$0.06

Genetic Technologies Stock Forecast and Price Target

Given the average yearlong price target of $0.06 provided by prominent analysts over the past few months, there is a potential downside of approximately -50% from the last closing price in April, 2024 for Genetic Technologies's stock if it is reached. This estimation is based on a high estimate of $0.07 and a low estimate of $0.05. Even if you are not interested in GTG stock, it is still imperative to be aware of its competitors.

$0.06

-50.00% Downside

Genetic Technologies Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, Genetic Technologies's Price has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Genetic Technologies, with analysts predicting Fair Value of $0.12 – an increase of 100.00%. Over the next seven years, experts anticipate that Genetic Technologies's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$0.12
2025 Fair Value Forecast
$0.13
2026 Fair Value Forecast
$0.15
2027 Fair Value Forecast
$0.16
2028 Fair Value Forecast
$0.17
2029 Fair Value Forecast
$0.19
2030 Fair Value Forecast
$0.21

Genetic Technologies Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Genetic Technologies's Revenue has grown, increasing from $10000.00 to $10.35M – a growth of 103400.00%. In the following year, 0 experts forecast Genetic Technologies's Revenue will decrease by 65.86%, to $3.53M. In 2030, professionals predict that Genetic Technologies's Revenue will decrease by 31.96%, to $7.04M.

2024 Rev Forecast
$0.00B
2025 Rev Forecast
$0.00B
2026 Rev Forecast
$0.01B
2027 Rev Forecast
$0.01B
2028 Rev Forecast
$0.01B
2029 Rev Forecast
$0.01B
2030 Rev Forecast
$0.01B

Genetic Technologies Dividend per Share Forecast for 2023 - 2025 - 2030

Genetic Technologies Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-4100000.00
2025 FCF Forecast
$0.00
2026 FCF Forecast
$0.00
2027 FCF Forecast
$0.00
2028 FCF Forecast
$0.00
2029 FCF Forecast
$0.00
2030 FCF Forecast
$0.00

Genetic Technologies EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Genetic Technologies's EBITDA has grown by 37.35%, rising from $-7.31M to $-10.04M. According to 1 analysts, Genetic Technologies's EBITDA will fall by 57.17% in the next year, reaching $-4.30M. Over the next seven years, experts predict that Genetic Technologies's EBITDA will grow at a rate of 68.92%.

2024 EBITDA Forecast
$-4300000.00
2025 EBITDA Forecast
$-300000.00
2026 EBITDA Forecast
$-1728970.00
2027 EBITDA Forecast
$-9706264.68
2028 EBITDA Forecast
$-47511842.08
2029 EBITDA Forecast
$-8803944.34
2030 EBITDA Forecast
$-16959624.91

Genetic Technologies EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Genetic Technologies's EBIT has grown by 41.19%, rising from $-7.38M to $-10.42M. In the following year, 1 experts forecast that Genetic Technologies's EBIT will decrease by 57.77%, to $-4.40M. Over the next seven years, experts predict that Genetic Technologies's EBIT will grow at a rate of 14.63%.

2024 EBIT Forecast
$-4400000.00
2025 EBIT Forecast
$-400000.00
2026 EBIT Forecast
$-1866626.67
2027 EBIT Forecast
$-8451152.23
2028 EBIT Forecast
$-32213538.67
2029 EBIT Forecast
$-7489647.74
2030 EBIT Forecast
$-11944240.56

Genetic Technologies EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, Genetic Technologies's EPS has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Genetic Technologies, with analysts predicting EPS of $-43.20 – an increase of 100.00%. Over the next seven years, experts anticipate that Genetic Technologies's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-43.20
2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00